Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 3
2004 9
2005 11
2006 13
2007 7
2008 10
2009 8
2010 8
2011 9
2012 10
2013 7
2014 8
2015 10
2016 7
2017 10
2018 10
2019 10
2020 17
2021 9
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.
Fujiwara-Tani R, Mori S, Ogata R, Sasaki R, Ikemoto A, Kishi S, Kondoh M, Kuniyasu H. Fujiwara-Tani R, et al. Among authors: kondoh m. Int J Mol Sci. 2023 Mar 13;24(6):5494. doi: 10.3390/ijms24065494. Int J Mol Sci. 2023. PMID: 36982569 Free PMC article. Review.
Japanese Regulatory Considerations for Interoperability of Medical Devices.
Ishimoto K, Arafune T, Washio T, Haishima Y, Koichiro Matsumoto, Uematsu M, Nomura Y, Yokoi H, Sato H, Madoka Murakami, Okazaki Y, Tachibana K, Kondoh M. Ishimoto K, et al. Among authors: kondoh m. Ther Innov Regul Sci. 2023 Jan;57(1):104-108. doi: 10.1007/s43441-022-00444-7. Epub 2022 Aug 22. Ther Innov Regul Sci. 2023. PMID: 35994203 Review.
SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression.
Hashimoto R, Takahashi J, Shirakura K, Funatsu R, Kosugi K, Deguchi S, Yamamoto M, Tsunoda Y, Morita M, Muraoka K, Tanaka M, Kanbara T, Tanaka S, Tamiya S, Tokunoh N, Kawai A, Ikawa M, Ono C, Tachibana K, Kondoh M, Obana M, Matsuura Y, Ohsumi A, Noda T, Yamamoto T, Yoshioka Y, Torisawa YS, Date H, Fujio Y, Nagao M, Takayama K, Okada Y. Hashimoto R, et al. Among authors: kondoh m. Sci Adv. 2022 Sep 23;8(38):eabo6783. doi: 10.1126/sciadv.abo6783. Epub 2022 Sep 21. Sci Adv. 2022. PMID: 36129989 Free PMC article.
Recent advances in claudin-targeting technology.
Nagase S, Doyama R, Yagi K, Kondoh M. Nagase S, et al. Among authors: kondoh m. Biol Pharm Bull. 2013;36(5):708-14. doi: 10.1248/bpb.b13-00014. Biol Pharm Bull. 2013. PMID: 23649330 Free article. Review.
Homoharringtonine is a transdermal granular permeation enhancer.
Watari A, Fujiwara K, Yagi K, Tachibana K, Katsurada T, Myoui A, Kondoh M. Watari A, et al. Among authors: kondoh m. Biochem Biophys Res Commun. 2022 Aug 6;616:140-144. doi: 10.1016/j.bbrc.2022.04.067. Epub 2022 Apr 18. Biochem Biophys Res Commun. 2022. PMID: 35679696
Proof of concept for claudin-targeted drug development.
Suzuki H, Kondoh M, Takahashi A, Yagi K. Suzuki H, et al. Among authors: kondoh m. Ann N Y Acad Sci. 2012 Jul;1258:65-70. doi: 10.1111/j.1749-6632.2012.06503.x. Ann N Y Acad Sci. 2012. PMID: 22731717 Review.
174 results